EUVIMEDEUVIMED entdecken
Crossref

Mutant superoxide dismutase 1-catalyzed hydrogen therapy for amyotrophic lateral sclerosis achieved by intercepting oxidative stress–neuroinflammation crosstalk

Yihui Sun, Yingshuai Wang, Qianbo He, Min Zhao, Jiaru Guo, Chunjie Xu, Qiupeng Yan, Yanchun Chen, Bingqiang Zhang, Hongmei Du, Jing Huo, Yong Zhang und 3 weitere

Acta Biomaterialia · 2026-08 · 219 · 663-678

DOI: 10.1016/j.actbio.2026.07.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-08. Verfasst von Yihui Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Science, Shandong Second Medical University, Weifang, 261053, China; Neurologic Disorders and Regenerative Repair Lab of Shan…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Oxidative Stress, Hydrogen, Superoxide Dismutase-1. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron degeneration in the brain and spinal cord, with mutant superoxide dismutase 1 (SOD1) induced oxidative stress and neuroinflammation as key pathogenic drivers. Here, we uncover that mutant SOD1 is both a Fenton-like agent able for catalytical generation of ·OH and a hydrogenation catalyst for H2 scavenging reactive oxygen species. To enhance the bioavailability of H2, we develop an orally administered Mg2Si nanosheets based feed for sustained release of high-amount H2. On an ALS model of hSOD1G93A transgenic mice, Mg2Si feed remarkably delays ALS progression, improves the motor performance of ALS mice, and extends their lifespan. Histopathologically, oral Mg2Si treatment ameliorates motor neuron degeneration, misfolded SOD1 aggregation and reactive gliosis in spinal cord, while protecting neuromuscular junctions and ameliorating muscle atrophy during disease progression. Transcriptomic analysis demonstrates the H2-mediated down-regulation of both oxidative stress and neuroinflammatory pathways in response to the suppression of NLRP3 inflammasome activation. The proposed strategy of catalyzed hydrogen therapy offers an inspiration for metalloproteases-related neurodegenerative diseases treatment. STATEMENT OF SIGNIFICANCE: Amyotrophic lateral sclerosis (ALS) is an incurable and devastating neurodegenerative disease lacking effective clinical interventions. Although hydrogen gas (H2) exhibits promising neuroprotective potential, conventional H2 therapy is severely limited by unstable and transient H2 release, failing to sustain long-term treatment requirements for chronic ALS pathogenesis. To overcome this bottleneck, we engineer oral administrable Mg2Si nanosheets that enable sustained H2 release via gastrointestinal retention, achieving stable long-term hydrogen supplementation in vivo. Mechanistically, Mg2Si-derived H2 efficiently eliminates excess free radicals triggered by toxic mutant SOD1, and further disrupts the pathological crosstalk between oxidative stress and neuroinflammation in ALS. In transgenic ALS mice, dietary Mg2Si intervention markedly ameliorates motor dysfunction and effectively delays disease progression. Collectively, this study firstly applies Mg2Si nanomaterial-based sustained hydrogen therapy for ALS treatment, establishes a novel gastrointestinal hydrogen delivery strategy, and provides an innovative and clinically translatable paradigm for the design of hydrogen delivery systems against neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisOxidative StressHydrogenSuperoxide Dismutase-1Neuroinflammatory DiseasesMutationAnimalsMiceMice, TransgenicHumansSpinal Cord

Stichwörter der Autor:innen

Amyotrophic lateral sclerosisHydrogen therapyNeuroinflammationOxidative stress

Substanzen

HydrogenSuperoxide Dismutase-1

Autor:innen und Institutionen

  • School of Basic Medical Science, Shandong Second Medical University, Weifang, 261053, China; Neurologic Disorders and Regenerative Repair Lab of Shandong Higher Education, Shandong Second Medical University, Weifang, 26…
  • School of Life Sciences and Technology, Shandong Second Medical University, Weifang, 261053, China; Department of Intensive Care Unit, Affiliated Hospital of Shandong Second Medical University, Weifang, 261053, PR China.
  • Zhejiang Zhongyi Pharmaceutical Co., Ltd, Hangzhou, 310022, China.
  • Qingdao Restore Medical Laboratory, Qingdao, 266000, China.
  • School of Life Sciences and Technology, Shandong Second Medical University, Weifang, 261053, China.
  • Department of Intensive Care Unit, Affiliated Hospital of Shandong Second Medical University, Weifang, 261053, PR China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, Y., Wang, Y., He, Q., Zhao, M., Guo, J., Xu, C., Yan, Q., Chen, Y., Zhang, B., Du, H., Huo, J., Zhang, Y., Zhang, H., Guan, Y., & He, Q. (2026). Mutant superoxide dismutase 1-catalyzed hydrogen therapy for amyotrophic lateral sclerosis achieved by intercepting oxidative stress–neuroinflammation crosstalk. Acta Biomaterialia, 219, 663-678. https://doi.org/10.1016/j.actbio.2026.07.004

Vancouver

Sun Y, Wang Y, He Q, Zhao M, Guo J, Xu C, et al. Mutant superoxide dismutase 1-catalyzed hydrogen therapy for amyotrophic lateral sclerosis achieved by intercepting oxidative stress–neuroinflammation crosstalk. Acta Biomaterialia. 2026;219:663-678. doi:10.1016/j.actbio.2026.07.004

BibTeX
@article{Sun2026,
  author = {Sun, Yihui and Wang, Yingshuai and He, Qianbo and Zhao, Min and Guo, Jiaru and Xu, Chunjie and Yan, Qiupeng and Chen, Yanchun and Zhang, Bingqiang and Du, Hongmei and Huo, Jing and Zhang, Yong and Zhang, Haoyun and Guan, Yingjun and He, Qianjun},
  title = {Mutant superoxide dismutase 1-catalyzed hydrogen therapy for amyotrophic lateral sclerosis achieved by intercepting oxidative stress–neuroinflammation crosstalk},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {219},
  pages = {663--678},
  doi = {10.1016/j.actbio.2026.07.004}
}
Kostenlos starten →